These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15890937)

  • 1. Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.
    Sugimoto K; Kaplan DE; Ikeda F; Ding J; Schwartz J; Nunes FA; Alter HJ; Chang KM
    J Virol; 2005 Jun; 79(11):6976-83. PubMed ID: 15890937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.
    Prince AM; Brotman B; Lee DH; Pfahler W; Tricoche N; Andrus L; Shata MT
    J Infect Dis; 2005 Nov; 192(10):1701-9. PubMed ID: 16235167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.
    Schulze Zur Wiesch J; Lauer GM; Timm J; Kuntzen T; Neukamm M; Berical A; Jones AM; Nolan BE; Longworth SA; Kasprowicz V; McMahon C; Wurcel A; Lohse AW; Lewis-Ximenez LL; Chung RT; Kim AY; Allen TM; Walker BD
    Blood; 2007 Sep; 110(5):1559-69. PubMed ID: 17475911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
    Humphreys IS; von Delft A; Brown A; Hibbert L; Collier JD; Foster GR; Rahman M; Christian A; Klenerman P; Barnes E
    Gut; 2012 Nov; 61(11):1589-99. PubMed ID: 22337948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
    Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
    J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two hepatitis C virus typing assays in a Tunisian population].
    Ben Moussa M; Barguellil F; Bouziani A; Amor A
    Ann Biol Clin (Paris); 2003; 61(2):234-8. PubMed ID: 12702482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients.
    Losikoff PT; Mishra S; Terry F; Gutierrez A; Ardito MT; Fast L; Nevola M; Martin WD; Bailey-Kellogg C; De Groot AS; Gregory SH
    J Hepatol; 2015 Jan; 62(1):48-55. PubMed ID: 25157982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L; Shoukry NH; Grá B; Amador-Cañizares Y; Helle F; Bédard N; Guerra I; Drouin C; Dubuisson J; González-Horta EE; Martínez G; Marante J; Cinza Z; Castellanos M; Dueñas-Carrera S
    J Viral Hepat; 2009 Mar; 16(3):156-67. PubMed ID: 19017255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.
    Chuang WC; Allain JP
    J Gen Virol; 2008 Aug; 89(Pt 8):1890-1900. PubMed ID: 18632960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential virus-specific CD8
    Luxenburger H; Graß F; Baermann J; Boettler T; Marget M; Emmerich F; Panning M; Thimme R; Nitschke K; Neumann-Haefelin C
    J Viral Hepat; 2018 Jul; 25(7):779-790. PubMed ID: 29397015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
    Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.
    Giugliano S; Oezkan F; Bedrejowski M; Kudla M; Reiser M; Viazov S; Scherbaum N; Roggendorf M; Timm J
    Hepatology; 2009 Sep; 50(3):707-16. PubMed ID: 19637188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.
    Sugimoto K; Stadanlick J; Ikeda F; Brensinger C; Furth EE; Alter HJ; Chang KM
    Hepatology; 2003 Mar; 37(3):590-9. PubMed ID: 12601357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.
    Sugimoto K; Ikeda F; Stadanlick J; Nunes FA; Alter HJ; Chang KM
    Hepatology; 2003 Dec; 38(6):1437-48. PubMed ID: 14647055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.